Product Information
PREVALITE POWDER is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1698 per GM under NDC 00245003623. Its NADAC has been published 646 times since Nov 28, 2013.
FDA first approved this application on Feb 22, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/5.5g
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245003623
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA073263FDA Approved
2/22/1996
TE Code
AB
On Market Since
2/1/1996
Pharmacological Classes
Price Statistics
The NADAC for PREVALITE POWDER has been published 646 times since Nov 28, 2013, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1698 per GM |
|---|---|
| All-time high | $0.2998 (Jan 11, 2017) |
| All-time low | $0.1343 (Nov 20, 2024) |
| 52-week high | $0.1704 |
| 52-week low | $0.1471 |
| Median price | $0.2238 |
| Average price | $0.2207 |
| Largest weekly change | +42.1% (Sep 23, 2020) |
| Weeks tracked | 646 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cholestyramine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREVALITE POWDER?
The current National Average Drug Acquisition Cost (NADAC) for PREVALITE POWDER, manufactured by Upsher-Smith Laboratories LLC, is $0.1698 per GM (NDC 00245003623), effective Sep 30, 2026.
How has the price of PREVALITE POWDER changed over time?
Over the history we have for it, the NADAC for PREVALITE POWDER has declined 37.9%. It has been tracked across 646 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREVALITE POWDER?
Since Nov 28, 2013, the NADAC for PREVALITE POWDER has ranged from a low of $0.1343 (Nov 20, 2024) to a high of $0.2998 (Jan 11, 2017), with a median of $0.2238 per GM.
Are there cheaper alternatives to PREVALITE POWDER?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE POWDER, is $0.0924 per GM — about 46% below PREVALITE POWDER.
Who manufactures PREVALITE POWDER?
PREVALITE POWDER (NDC 00245003623) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.